← Leaderboards
Spiros Kambourakis
Cellibre Inc
$1,999,908
Attributed
$1,999,908
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1000K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,999,908 · 1
By mechanism
R44$1,999,908 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Acids”
- Rino Rappuoli · Washington University$14,702,884
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Christine W Hockett · Avera Mckennan$8,908,366
- Victoria Coleman · Leidos Biomedical Research, Inc.$7,090,787
- Brian J Lopresti · University Of Pittsburgh At Pittsburgh$6,934,890
- Rangarajan Sampath · Siemens Healthcare Diagnostics Inc.$5,422,657
Research focus
AcidsAddictionAgricultureAnalogAnti-Bacterial AgentsBiomedical EngineeringBioreactorsCannabigerolCannabigerolic AcidCannabinoid DrugCannabinoidsCannabinoid TreatmentCannabisCannabis Sativa PlantClinical TrialsCnr1 GeneCnr2 GeneCommercializationComplexConsumptionCostCost EffectiveDecarboxylationAcceleration
Grant awards (2)
A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds$999,954
R44 · FY2025 · AT · contact PI
A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds$999,954
R44 · FY2024 · AT · contact PI